Patents Assigned to Virothera Pharmaceuticals LLC
  • Patent number: 11178923
    Abstract: An environmentally natural protective and therapeutic (ENPT) mask and an associated method of forming the ENPT mask. The ENPT mask includes: a face mask; and one or more essential oils embedded in the face mask. The one or more essential oils are configured to destroy microbes in direct physical contact with the one or more essential oils. The method of forming the ENPT mask includes embedding the one or more essential oils in the face mask.
    Type: Grant
    Filed: May 8, 2020
    Date of Patent: November 23, 2021
    Assignee: Virothera Pharmaceuticals LLC
    Inventors: Shaker A. Mousa, Ali Hafez Ali Mohammed ElFar
  • Patent number: 10993909
    Abstract: A composition and method for treating a mammal infected with a virus therein, and an inhalation delivery system for prevention and treatment of upper respiratory tract viruses, by administering a therapeutic dose of the composition to the mammal. The composition includes: microparticles and/or nanoparticles, wherein a pharmaceutically active agent, corticosteroid and/or hydroxychloroquine, niclosamide, and/or favipiravir, and a zinc salt are incorporated in the microparticles and/or nanoparticles. The pharmaceutically active agent is unfractionated heparin (UFH), Low Molecular Weight Heparin (LMWH), sulfated non-anticoagulant heparin (S-NACH), other glycosaminoglycans (GAGs), or combinations thereof.
    Type: Grant
    Filed: June 19, 2020
    Date of Patent: May 4, 2021
    Assignee: Virothera Pharmaceuticals LLC
    Inventor: Shaker A. Mousa